Pfizer 2013 Annual Report Download - page 123
Download and view the complete annual report
Please find page 123 of the 2013 Pfizer annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.-
1 -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
31
-
32
-
33
-
34
-
35
-
36
-
37
-
38
-
39
-
40
-
41
-
42
-
43
-
44
-
45
-
46
-
47
-
48
-
49
-
50
-
51
-
52
-
53
-
54
-
55
-
56
-
57
-
58
-
59
-
60
-
61
-
62
-
63
-
64
-
65
-
66
-
67
-
68
-
69
-
70
-
71
-
72
-
73
-
74
-
75
-
76
-
77
-
78
-
79
-
80
-
81
-
82
-
83
-
84
-
85
-
86
-
87
-
88
-
89
-
90
-
91
-
92
-
93
-
94
-
95
-
96
-
97
-
98
-
99
-
100
-
101
-
102
-
103
-
104
-
105
-
106
-
107
-
108
-
109
-
110
-
111
-
112
-
113 -
114 -
115 -
116 -
117 -
118 -
119 -
120 -
121 -
122 -
123
 |
 |
Peer Group Performance Graph
Pfizer Inc. and Subsidiary Companies
122 2013 Financial Report
The following graph assumes a $100 investment on December 31, 2008, and reinvestment of all dividends, in each of the Company's
Common Shares, the S&P 500 Index, and a composite peer group of the major U.S.- and European-based pharmaceutical companies, which
are: Abbott Laboratories (for the period 2008-2012 only), AbbVie Inc. (for 2013 only), Amgen, Inc., AstraZeneca plc, Bristol-Myers Squibb
Company, Eli Lilly & Co., GlaxoSmithKline plc, Johnson & Johnson, Merck and Co., Inc., Novartis AG, Roche Holding AG and Sanofi SA.
Five Year Performance
2008 2009 2010 2011 2012 2013
PFIZER $100.0 $108.3 $108.6 $139.8 $168.4 $212.5
PEER GROUP $100.0 $114.5 $115.0 $132.0 $148.5 $198.1
S&P 500 $100.0 $126.4 $145.5 $148.6 $172.3 $228.1